Market overview
The global immunohistochemistry market is worth USD 3.5 bn in 2026 and is forecast to reach USD 7.5 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Antibodies is the largest by product segment.
| Scope | Antibodies, reagents, detection kits, automated staining instruments and consumables used in immunohistochemistry testing of tissue samples in pathology and research laboratories. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 3.2 bn |
| Value 2026 | USD 3.5 bn |
| Value 2036 | USD 7.5 bn |
| CAGR 2026-2036 | 8.0% |
| Volume 2026 | 214 million tests |
| Volume 2036 | 418 million tests |
| Average price 2026 | USD 16.2 per test |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Immunohistochemistry market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 3.5 bn |
| 2027 | USD 3.7 bn |
| 2028 | USD 4.0 bn |
| 2029 | USD 4.4 bn |
| 2030 | USD 4.7 bn |
| 2031 | USD 5.1 bn |
| 2032 | USD 5.5 bn |
| 2033 | USD 5.9 bn |
| 2034 | USD 6.4 bn |
| 2035 | USD 6.9 bn |
| 2036 | USD 7.5 bn |
Immunohistochemistry market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Antibodies | 38.0% | 36.1% | USD 1.3 bn | 7.4% |
| Reagents and kits | 32.0% | 33.3% | USD 1.1 bn | 8.4% |
| Instruments and automated stainers | 22.0% | 21.9% | USD 760 mn | 7.9% |
| Software and consumables | 8.0% | 8.7% | USD 276 mn | 8.9% |
By application
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Cancer diagnostics | 70.0% | 72.7% | USD 2.4 bn | 8.4% |
| Infectious and autoimmune disease | 10.0% | 9.0% | USD 346 mn | 6.9% |
| Drug discovery and research | 15.0% | 14.2% | USD 518 mn | 7.4% |
| Other | 5.0% | 4.1% | USD 173 mn | 5.9% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals and diagnostic laboratories | 58.0% | 58.9% | USD 2.0 bn | 8.2% |
| Pharma and biotech | 22.0% | 23.4% | USD 760 mn | 8.7% |
| Academic and research institutes | 20.0% | 17.7% | USD 691 mn | 6.7% |
By detection
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Chromogenic | 54.0% | 48.0% | USD 1.9 bn | 6.7% |
| Fluorescent | 24.0% | 26.0% | USD 829 mn | 8.9% |
| Multiplex | 22.0% | 26.0% | USD 760 mn | 9.8% |
By sample type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Formalin-fixed paraffin-embedded tissue | 68.0% | 62.0% | USD 2.4 bn | 7.0% |
| Frozen tissue | 16.0% | 16.0% | USD 553 mn | 8.0% |
| Cytology and cell preparations | 16.0% | 22.0% | USD 553 mn | 11.5% |
Top 25 countries for immunohistochemistry by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 85.5% of 2026 revenue and the 25 countries below together hold 95.9%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 1.3 bn | 38.0% | USD 2.7 bn | 7.4% |
| 2 | China | USD 484 mn | 14.0% | USD 1.4 bn | 10.9% |
| 3 | Germany | USD 242 mn | 7.0% | USD 448 mn | 6.3% |
| 4 | Japan | USD 207 mn | 6.0% | USD 366 mn | 5.8% |
| 5 | United Kingdom | USD 173 mn | 5.0% | USD 336 mn | 6.9% |
| 6 | France | USD 138 mn | 4.0% | USD 261 mn | 6.6% |
| 7 | Italy | USD 104 mn | 3.0% | USD 194 mn | 6.5% |
| 8 | India | USD 104 mn | 3.0% | USD 321 mn | 12.0% |
| 9 | Canada | USD 104 mn | 3.0% | USD 209 mn | 7.3% |
| 10 | South Korea | USD 86 mn | 2.5% | USD 194 mn | 8.4% |
| 11 | Spain | USD 38 mn | 1.1% | USD 76 mn | 7.3% |
| 12 | Australia | USD 38 mn | 1.1% | USD 76 mn | 7.3% |
| 13 | Brazil | USD 32 mn | 0.9% | USD 81 mn | 9.7% |
| 14 | Netherlands | USD 27 mn | 0.8% | USD 54 mn | 7.3% |
| 15 | Switzerland | USD 27 mn | 0.8% | USD 54 mn | 7.3% |
| 16 | Mexico | USD 21 mn | 0.6% | USD 54 mn | 9.8% |
| 17 | Taiwan | USD 21 mn | 0.6% | USD 43 mn | 7.3% |
| 18 | Russia | USD 21 mn | 0.6% | USD 43 mn | 7.3% |
| 19 | Turkey | USD 21 mn | 0.6% | USD 54 mn | 9.8% |
| 20 | Belgium | USD 21 mn | 0.6% | USD 43 mn | 7.3% |
| 21 | Sweden | USD 21 mn | 0.6% | USD 43 mn | 7.3% |
| 22 | Singapore | USD 21 mn | 0.6% | USD 54 mn | 9.8% |
| 23 | Poland | USD 16 mn | 0.5% | USD 33 mn | 7.3% |
| 24 | Denmark | USD 16 mn | 0.5% | USD 33 mn | 7.3% |
| 25 | Saudi Arabia | USD 16 mn | 0.5% | USD 41 mn | 9.7% |
| Rest of world | USD 141 mn | 4.1% | USD 296 mn | 7.7% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Roche
- Agilent Technologies
- Leica Biosystems
- Thermo Fisher Scientific
- Merck KGaA
Group 2: Regional and specialist players
- Abcam
- Cell Signaling Technology
- Bio-Techne
- Sakura Finetek
- Epredia
- Cell Marque
- Maixin Biotech
- ZSGB-BIO
- Zytomed Systems
Group 3: Emerging and niche players
- Biocare Medical
- BioGenex
- Diagnostic BioSystems
- Histo-Line Laboratories
- Akoya Biosciences
- Vector Laboratories
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the immunohistochemistry market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.0% is calculated from the resulting values.
The market is divided by product, by application, by end user, by detection, by sample type. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the immunohistochemistry market?
The global immunohistochemistry market is estimated at USD 3.2 bn in 2025 and USD 3.5 bn in 2026.
How fast will the immunohistochemistry market grow?
It is forecast to reach USD 7.5 bn by 2036, a compound annual growth rate of 8.0% from 2026, an increase of USD 4.0 bn.
Which country is the largest market for immunohistochemistry?
United States is the largest market by revenue at USD 1.3 bn in 2026, 38.0% of the global total. The three largest countries together hold 59.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 12.0% a year from 2026 to 2036.
Which immunohistochemistry segment is largest?
In the by product split, Antibodies is the largest segment with 38.0% of 2026 revenue.
Who are the leading immunohistochemistry companies?
Global leaders include Roche, Agilent Technologies, Leica Biosystems, Thermo Fisher Scientific.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Healthcare Provider Workflow OptimizationUSD 3.4 bn · 10.5% CAGR
- CapsuleUSD 3.4 bn · 6.5% CAGR
- Neurorehabilitation TechnologyUSD 3.4 bn · 9.0% CAGR
- AutoinjectorUSD 3.7 bn · 10.0% CAGR
- BiobankingUSD 3.2 bn · 8.5% CAGR
- Pharmaceutical SerializationUSD 3.7 bn · 9.0% CAGR
- Lyophilization EquipmentUSD 3.1 bn · 7.6% CAGR
- Continuous Positive Airway Pressure (CPAP)USD 3.1 bn · 6.5% CAGR